跳至主要内容
临床试验/NCT02302326
NCT02302326已完成不适用

Involvement of Reticulum Endoplasmic Stress in the Physiopathology of Polycystic Ovary Syndrome: Possible Therapeutic Implications of Insulin Sensitizers.

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2013年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50
试验地点
1
主要终点
Changes in apoptotic parameters in controls and pcos women before and after metformin/Myo-inositol + folic acid administration

研究概览

简要总结

The main objective of the present project is to evaluate the relevance of reticulum stress in the pathogenesis of polycystic ovary syndrome (PCOS), focusing particularly on the underlying mechanisms of insulin resistance, which is the origin of metabolic comorbidities. Furthermore, the investigators will assess the potential of insulin sensitizers as a treatment to control endoplasmic reticulum stress markers in PCOS patients.

详细描述

To do this, the investigators will evaluate anthropometric, biochemical and hormone parameters, lipid profile and cardiovascular risk markers (using enzymatic and biochemical techniques, nephelometry, enzyme-linked immunosorbent assay, radioimmunoassay), and markers of endoplasmic reticulum stress and the insulin pathway and inflammatory and apoptotic parameters (by means of Western blot, Real Time- Polymerase Chain Reaction (RT-PCR), Luminex® xMAP® Technology ) in patients with and without PCOS. The investigators' second objective is to evaluate (using the abovementioned methodology) the efficacy of different insulin sensitizers (myoinositol and metformin) administered to PCOS patients during a 3-month period after which the investigators will analyze different parameters of oxidative stress and mitochondrial function (using Clark electrode and fluorometric techniques).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women diagnosed with PCOS using the Rotterdam criteria
  • Women of reproductive age

排除标准

  • Organic, malignant, haematological, infectious or inflammatory disease
  • History of ischaemic heart disease (stroke or thromboembolism)
  • Diabetes mellitus,
  • Secondary causes of obesity (hypothyroidism, Cushing's syndrome)
  • Severe hypertension.
  • Smoking or alcohol habit

研究组 & 干预措施

Metformin

Experimental

PCOS women began treatment with ER 500 mg metformin per day, and the dose was increased to 1000 mg after 2 weeks, and to 1700 mg/d after a further 2 weeks, and was maintained at this dose for a total of 12 weeks.

干预措施: Metformin (Drug)

Myo-inositol + folic acid

Experimental

PCOS women received a dietary supplement (Ovusitol® : 4 g myo-inositol plus 400 micrograms of folic acid) for 12 weeks

干预措施: Myo-inositol + folic acid (Dietary Supplement)

结局指标

主要结局

Changes in apoptotic parameters in controls and pcos women before and after metformin/Myo-inositol + folic acid administration

时间窗: 3 months

Apoptotic parameters (transcription factor C/EBP homologous protein (CHOP) and caspase 12) were assessed by Western Blot and Real Time- Polymerase Chain Reaction (RT-PCR) in polymorphonuclear cells

Changes in inflammatory parameters in controls and pcos women before and after metformin/Myo-inositol + folic acid administration

时间窗: 3 months

Inflammatory parameters (nuclear factor κB (NF-κB), interleukin-6 (IL6), tumor necrosis factor α (TNFα)) were assessed by Western Blot, Real Time- Polymerase Chain Reaction (RT-PCR), or Luminex® xMAP® Technology in polymorphonuclear cells and serum

Changes in markers of endoplasmic reticulum stress in controls and pcos women before and after metformin/Myo-inositol + folic acid administration

时间窗: 3 months

Markers of endoplasmic reticulum stress (78-kDa glucose-regulated protein (GRP78), ubiquitous translation initiation factor 2α (eIF2α), double-stranded RNA-activated protein kinase (PERK), inositol requiring enzyme 1 (IRE1α), X-box binding protein 1 (XBP-1)) were assessed by Western Blot and Real Time- Polymerase Chain Reaction (RT-PCR) in polymorphonuclear cells

Changes in markers of the insulin pathway in controls and pcos women before and after metformin/Myo-inositol + folic acid administration

时间窗: 3 months

Markers of the insulin pathway (c-Jun N-terminal kinase (JNK), insulin receptor substrate (IRS)) were assessed by Western Blot and Real Time- Polymerase Chain Reaction (RT-PCR) in polymorphonuclear cells

次要结局

  • Changes in biochemical parameters in controls and pcos women before and after metformin/Myo-inositol + folic acid administration(3 months)
  • Changes in mitochondrial function parameters in controls and pcos women before and after metformin/Myo-inositol + folic acid administration(3 months)
  • Changes in endothelial function parameters in controls and pcos women before and after metformin/Myo-inositol + folic acid administration(3 months)
  • Changes in anthropometric parameters in controls and pcos women before and after metformin/Myo-inositol + folic acid administration(3 months)

研究者

发起方
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
申办方类型
Other
责任方
Principal Investigator
主要研究者

Antonio Hernandez Mijares

PhD, MD

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

研究点 (1)

Loading locations...

相似试验

Involvement of Reticulum Endoplasmic Stress in the... | 临床试验